Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Parkinson Disease: HELP
David S. Park
Based on 17 articles published since 2008
||||
Expertise Level
The expertise of David S. Park ranks in the
  • Top 1.8%
  • ... of 69,482 published authors worldwide on Parkinson Disease
  • ... from 2008 through 2019
  • ... based on contributions to 17 articles on the topic.
Graphical view (beta)
Uncounted papers?
Aliases Park, David S   ·   Park, D S   ·   Park, David
Work Locations
Details
Most likely:    University of Ottawa      
2018
  • Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada. · Brain and Mind Research Institute, University of Ottawa, Ottawa, ON K1H 8M5, Canada. · Ottawa Institute of Systems Biology, University of Ottawa, Ottawa, ON K1H 0M5, Canada. · Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, University Health Network, Toronto, ON M5T 2S8, Canada. · Edmond J. Safra Program in Parkinson's Disease, University of Toronto, Toronto, ON M5S 1A8, Canada. · Division of Neuroscience, Ottawa Hospital Research Institute, The Ottawa Hospital, Ottawa, ON K1H 8M5, Canada. · Division of Neurology, The Ottawa Hospital, Ottawa, ON K1H 8M5, Canada. · Division of Neurology, Department of Medicine, Toronto Western Hospital, University Health Network, Toronto, ON M5T 2S8, Canada. · Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada; · Pubmed 29760073
  • From the Departments of Pharmacology and Physiology and. · Neurosciences. · the Department of Clinical and Experimental Medicine, University of Foggia, Foggia 71122, Italy. · the Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Québec, Montreal H2X 0A9, Canada. · the Faculty of Pharmacy, Université de Montréal, Québec, Montreal H4T 1J4, Canada. · the Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario K1M 8M5, Canada. · From the Departments of Pharmacology and Physiology and · Central Nervous System Research Group (GRSNC), Faculty of Medicine, Université de Montréal, Québec, Montreal H4T 1J4, Canada. · Pubmed 29700116
2017
  • University of Ottawa Brain and Mind Research Institute, Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada, K1H 8M5. · Center of Excellence on Neurodegenerative Diseases, Department of Pharmacological Sciences, University of Milan, Via Balzaretti 9, 20133, Milan, Italy. · Center of Excellence on Neurodegenerative Diseases, Department of Oncology and Hemato-Oncology, University of Milan, Via Balzaretti 9, 20133, Milan, Italy. · Centre for Cancer Therapeutics, Ottawa Hospital Research Institute and Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, ON, Canada, K1H 8M5. · Institute of Neurogenetics, University of Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Germany. · Department of Biochemistry, Microbiology and Immunology, Department of Chemistry and Biomolecular Sciences, and Ottawa Institute of Systems Biology, University of Ottawa, Ottawa, ON, Canada, K1H 8M5. · University of Ottawa Brain and Mind Research Institute, Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada, K1H 8M5. · Pubmed 29123128
  • Neurogenomics Laboratory and Parkinson Personalized Medicine Program, Harvard Medical School and Brigham and Women's Hospital, Boston, MA 02115, USA. · Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. · Department of Neurology, Brigham and Women's Hospital, Boston, MA 02115, USA. · Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway. · The Norwegian Multiple Sclerosis Competence Center, Department of Neurology, Haukeland University Hospital, Norway. · Brain and Mind Research Institute, Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario K1H 8M5, Canada. · The Parkinson's Institute and Clinical Center, Sunnyvale, CA 94085, USA. · Department of Neurology, Massachusetts General Hospital, Boston, MA 02114, USA. · Department of Pharmacology, University of California at Davis, Davis, CA 95616, USA. · Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN 47907, USA. · Department of Pharmacoepidemiology, Norwegian Institute of Public Health, Oslo, Norway. · German Center for Neurodegenerative Diseases (DZNE), Tübingen 72076, Germany. · Harvard NeuroDiscovery Center, Harvard Medical School, Boston, MA 02115, USA. · Harvard Stem Cell Institute, Cambridge, MA 02138, USA. · Neurogenomics Laboratory and Parkinson Personalized Medicine Program, Harvard Medical School and Brigham and Women's Hospital, Boston, MA 02115, USA. · Pubmed 28860381
  • Department of Cellular and Molecular Medicine. · Brain and Mind Research Institute, University of Ottawa, Ottawa, ON, Canada. · Department of Biochemistry, College of Medicine and Health Science, United Arab Emirates University, Al Ain, UAE. · Department of Biopharmaceutical Sciences, Keck Graduate Institute, Claremont, CA, USA. · Pubmed 28158614
2014
  • Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada. · Department of Medicine and Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at Univeristy of California Los Angeles, Los Angeles, California, United States of America. · Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, United States of America. · Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada; Fishberg Department of Neuroscience and Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America. · Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada; Department of Ophthalmology, Queen's University, Kingston, Ontario, Canada. · The Campbell Family Institute for Breast Cancer Research, Toronto, Ontario, Canada. · Ottawa Institute of Systems Biology (OISB), University of Ottawa, Ottawa, Ontario, Canada. · Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada; Department of Cogno-Mechatronics Engineering, Pusan National University, Busan, Korea. · Pubmed 25210784
  • Department of Cellular and Molecular Medicine. · Department of Cellular and Molecular Medicine, Department of Ophthalmology, Queen's University, Kingston, Ontario K7L 5G2, Canada. · The Campbell Family Institute for Breast Cancer Research, Toronto, Ontario M5G 2C1, Canada, and. · Institute of Systems Biology, University of Ottawa, Ottawa, Ontario K1H 8M5, Canada. · Department of Cellular and Molecular Medicine, Department of Cogno-Mechatronics Engineering, Pusan National University, Busan 609-735, Korea · Pubmed 24899725
2012
  • Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada. · Pubmed 23019375
2010
  • Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Canada. · Pubmed 20639397
2009
  • Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario K1H 8M5, Canada. · Pubmed 19351953
2008
  • Ottawa Health Research Institute, Neuroscience Group, University of Ottawa, Ottawa, ON, Canada. · Pubmed 18218782
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 17 total) written by David S. Park about Parkinson Disease:

  • Regulation of myeloid cell phagocytosis by LRRK2 via WAVE2 complex stabilization is altered in Parkinson's disease. 2018
  • Comparative analysis of Parkinson's disease-associated genes in mice reveals altered survival and bioenergetics of Parkin-deficient dopamine neurons. 2018
  • PINK1-mediated phosphorylation of LETM1 regulates mitochondrial calcium transport and protects neurons against mitochondrial stress. 2017
  • β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson's disease. 2017
  • LRRK2(I2020T) functional genetic interactors that modify eye degeneration and dopaminergic cell loss in Drosophila. 2017
  • DJ-1 interacts with and regulates paraoxonase-2, an enzyme critical for neuronal survival in response to oxidative stress. 2014
  • Regulation of the VHL/HIF-1 pathway by DJ-1. 2014
  • Programmed cell death in Parkinson's disease. 2012
  • Progressive dopaminergic cell loss with unilateral-to-bilateral progression in a genetic model of Parkinson disease. 2012
  • Selective neuroprotective effects of the S18Y polymorphic variant of UCH-L1 in the dopaminergic system. 2012
Show List of Full Article Records
Google Searches

Learn more about David S. Park using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Ottawa
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Ottawa
2018
  • Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada. · Brain and Mind Research Institute, University of Ottawa, Ottawa, ON K1H 8M5, Canada. · Ottawa Institute of Systems Biology, University of Ottawa, Ottawa, ON K1H 0M5, Canada. · Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, University Health Network, Toronto, ON M5T 2S8, Canada. · Edmond J. Safra Program in Parkinson's Disease, University of Toronto, Toronto, ON M5S 1A8, Canada. · Division of Neuroscience, Ottawa Hospital Research Institute, The Ottawa Hospital, Ottawa, ON K1H 8M5, Canada. · Division of Neurology, The Ottawa Hospital, Ottawa, ON K1H 8M5, Canada. · Division of Neurology, Department of Medicine, Toronto Western Hospital, University Health Network, Toronto, ON M5T 2S8, Canada. · Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada; · Pubmed 29760073
  • From the Departments of Pharmacology and Physiology and. · Neurosciences. · the Department of Clinical and Experimental Medicine, University of Foggia, Foggia 71122, Italy. · the Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Québec, Montreal H2X 0A9, Canada. · the Faculty of Pharmacy, Université de Montréal, Québec, Montreal H4T 1J4, Canada. · the Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario K1M 8M5, Canada. · From the Departments of Pharmacology and Physiology and · Central Nervous System Research Group (GRSNC), Faculty of Medicine, Université de Montréal, Québec, Montreal H4T 1J4, Canada. · Pubmed 29700116
2017
  • University of Ottawa Brain and Mind Research Institute, Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada, K1H 8M5. · Center of Excellence on Neurodegenerative Diseases, Department of Pharmacological Sciences, University of Milan, Via Balzaretti 9, 20133, Milan, Italy. · Center of Excellence on Neurodegenerative Diseases, Department of Oncology and Hemato-Oncology, University of Milan, Via Balzaretti 9, 20133, Milan, Italy. · Centre for Cancer Therapeutics, Ottawa Hospital Research Institute and Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, ON, Canada, K1H 8M5. · Institute of Neurogenetics, University of Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Germany. · Department of Biochemistry, Microbiology and Immunology, Department of Chemistry and Biomolecular Sciences, and Ottawa Institute of Systems Biology, University of Ottawa, Ottawa, ON, Canada, K1H 8M5. · University of Ottawa Brain and Mind Research Institute, Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada, K1H 8M5. · Pubmed 29123128
  • Neurogenomics Laboratory and Parkinson Personalized Medicine Program, Harvard Medical School and Brigham and Women's Hospital, Boston, MA 02115, USA. · Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. · Department of Neurology, Brigham and Women's Hospital, Boston, MA 02115, USA. · Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway. · The Norwegian Multiple Sclerosis Competence Center, Department of Neurology, Haukeland University Hospital, Norway. · Brain and Mind Research Institute, Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario K1H 8M5, Canada. · The Parkinson's Institute and Clinical Center, Sunnyvale, CA 94085, USA. · Department of Neurology, Massachusetts General Hospital, Boston, MA 02114, USA. · Department of Pharmacology, University of California at Davis, Davis, CA 95616, USA. · Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN 47907, USA. · Department of Pharmacoepidemiology, Norwegian Institute of Public Health, Oslo, Norway. · German Center for Neurodegenerative Diseases (DZNE), Tübingen 72076, Germany. · Harvard NeuroDiscovery Center, Harvard Medical School, Boston, MA 02115, USA. · Harvard Stem Cell Institute, Cambridge, MA 02138, USA. · Neurogenomics Laboratory and Parkinson Personalized Medicine Program, Harvard Medical School and Brigham and Women's Hospital, Boston, MA 02115, USA. · Pubmed 28860381
  • Department of Cellular and Molecular Medicine. · Brain and Mind Research Institute, University of Ottawa, Ottawa, ON, Canada. · Department of Biochemistry, College of Medicine and Health Science, United Arab Emirates University, Al Ain, UAE. · Department of Biopharmaceutical Sciences, Keck Graduate Institute, Claremont, CA, USA. · Pubmed 28158614
2014
  • Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada. · Department of Medicine and Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at Univeristy of California Los Angeles, Los Angeles, California, United States of America. · Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, United States of America. · Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada; Fishberg Department of Neuroscience and Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America. · Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada; Department of Ophthalmology, Queen's University, Kingston, Ontario, Canada. · The Campbell Family Institute for Breast Cancer Research, Toronto, Ontario, Canada. · Ottawa Institute of Systems Biology (OISB), University of Ottawa, Ottawa, Ontario, Canada. · Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada; Department of Cogno-Mechatronics Engineering, Pusan National University, Busan, Korea. · Pubmed 25210784
  • Department of Cellular and Molecular Medicine. · Department of Cellular and Molecular Medicine, Department of Ophthalmology, Queen's University, Kingston, Ontario K7L 5G2, Canada. · The Campbell Family Institute for Breast Cancer Research, Toronto, Ontario M5G 2C1, Canada, and. · Institute of Systems Biology, University of Ottawa, Ottawa, Ontario K1H 8M5, Canada. · Department of Cellular and Molecular Medicine, Department of Cogno-Mechatronics Engineering, Pusan National University, Busan 609-735, Korea · Pubmed 24899725
2012
  • Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada. · Pubmed 23019375
2010
  • Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Canada. · Pubmed 20639397
2009
  • Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario K1H 8M5, Canada. · Pubmed 19351953
2008
  • Ottawa Health Research Institute, Neuroscience Group, University of Ottawa, Ottawa, ON, Canada. · Pubmed 18218782
Unspecified
2017
  • Department of Cellular and Molecular Medicine. · Brain and Mind Research Institute, University of Ottawa, Ottawa, ON, Canada. · Department of Biochemistry, College of Medicine and Health Science, United Arab Emirates University, Al Ain, UAE. · Department of Biopharmaceutical Sciences, Keck Graduate Institute, Claremont, CA, USA. · Pubmed 28158614
5 Other Locations Show
Yearly article counts 023002031141
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.